Company intelligence / Profile preview
Hamlet BioPharma
Lund, Swedenhamletbiopharma.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Hamlet BioPharma develops novel peptide-based therapeutics derived from human milk protein alpha-lactalbumin. Its lead program, Alpha1H, has shown strong efficacy and safety in Phase I/II trials in non-muscle-invasive bladder cancer with no drug-related side effects. The company also advances immunotherapies targeting infections and inflammation as alternatives to antibiotics. Three projects are currently in Phase II clinical development; the pipeline includes ten pharmaceutical projects spanning oncology and infectious diseases.
- Therapeutic areas
- OncologyInfectious DiseasesNephrology
- Modalities
- Peptide-lipid complexes (e.g., HAMLET/Alpha1H)Immunotherapy agents targeting inflammation and infectionEndogenous inflammatory agents and bacterial moleculesSmall molecule inhibitors for infection/inflammation targets
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Collaboration with Lund University on research/mechanistic studies of Alpha1H/HAMLET platform.
Beyond the preview
Go deeper on Hamlet BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hamlet BioPharma.